Coagulation is associated with renal function decline and chronic kidney disease in people living with HIV in South Africa.

IF 2.9
Frontiers in nephrology Pub Date : 2026-05-22 eCollection Date: 2026-01-01 DOI:10.3389/fneph.2026.1800778
Joel Choshi, Haskly Mokoena, Sihle E Mabhida, Brian T Flepisi, Helen C Steel, Kabelo Mokgalaboni, Wendy N Phoswa, Gerald Maarman, Bongani B Nkambule, Phiwayinkosi V Dludla, Sidney Hanser
{"title":"Coagulation is associated with renal function decline and chronic kidney disease in people living with HIV in South Africa.","authors":"Joel Choshi, Haskly Mokoena, Sihle E Mabhida, Brian T Flepisi, Helen C Steel, Kabelo Mokgalaboni, Wendy N Phoswa, Gerald Maarman, Bongani B Nkambule, Phiwayinkosi V Dludla, Sidney Hanser","doi":"10.3389/fneph.2026.1800778","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic inflammation is a well-documented feature of human immunodeficiency virus (HIV) infection and is implicated in the progression of several comorbidities, including chronic kidney disease (CKD). Notably, chronic coagulation activation is another common phenomenon mediated by chronic inflammation among people living with HIV (PLWH) and has also been linked to CKD progression. However, the relationship between inflammation, coagulation and renal dysfunction remains underexplored in African populations with high HIV prevalence. This study investigated the association between systemic inflammation, coagulation activation and renal function among PLWH, particularly those receiving antiretroviral therapy (ART).</p><p><strong>Methods: </strong>In this cross-sectional study, 151 adults were enrolled, comprising 80 PLWH on ART, 27 PLWH not on ART, and 44 people not living with HIV (PNLWH). Inflammatory marker, C-reactive protein (CRP) and coagulation markers including fibrinogen and D-dimer, were measured and CKD stages were determined using estimated glomerular filtration rate (eGFR), which was calculated based on cystatin C (cystC) levels (eGFR<sub>cystC</sub>).</p><p><strong>Results: </strong>In the overall PLWH cohort, D-dimer was significantly associated with reduced eGFR<sub>cystC</sub> in both crude (<i>p</i> = 0.004) and adjusted analyses (<i>p</i> = 0.014), indicating poorer kidney function. Fibrinogen showed a significant association with reduced eGFR<sub>cystC</sub> only after adjusting for confounders (<i>p</i> = 0.048). Among PLWH on ART, D-dimer remained independently associated with reduced eGFR<sub>cystC</sub>, while fibrinogen showed an independent association after adjustment (β = -1.54, <i>p</i> = 0.031). Elevated fibrinogen levels were associated with an increased odds of CKD in the overall PLWH group (AOR = 1.12, 95% CI 1.00-1.23, <i>p</i> = 0.0 41), and elevated D-dimer levels were associated with increased odds of CKD among those on ART (AOR = 1.01, 95% CI 1.00-1.03, <i>p</i> = 0.045).</p><p><strong>Conclusion: </strong>The study reveals that both D-dimer and fibrinogen, key markers of coagulation are independently associated with renal function decline and risk of CKD in PLWH, particularly those on ART. These findings suggest that coagulation activation may be an early indicator of declining kidney function and increased risk of CKD in PLWH, potentially preceding overt systemic inflammation.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1800778"},"PeriodicalIF":2.9000,"publicationDate":"2026-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13236642/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fneph.2026.1800778","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic inflammation is a well-documented feature of human immunodeficiency virus (HIV) infection and is implicated in the progression of several comorbidities, including chronic kidney disease (CKD). Notably, chronic coagulation activation is another common phenomenon mediated by chronic inflammation among people living with HIV (PLWH) and has also been linked to CKD progression. However, the relationship between inflammation, coagulation and renal dysfunction remains underexplored in African populations with high HIV prevalence. This study investigated the association between systemic inflammation, coagulation activation and renal function among PLWH, particularly those receiving antiretroviral therapy (ART).

Methods: In this cross-sectional study, 151 adults were enrolled, comprising 80 PLWH on ART, 27 PLWH not on ART, and 44 people not living with HIV (PNLWH). Inflammatory marker, C-reactive protein (CRP) and coagulation markers including fibrinogen and D-dimer, were measured and CKD stages were determined using estimated glomerular filtration rate (eGFR), which was calculated based on cystatin C (cystC) levels (eGFRcystC).

Results: In the overall PLWH cohort, D-dimer was significantly associated with reduced eGFRcystC in both crude (p = 0.004) and adjusted analyses (p = 0.014), indicating poorer kidney function. Fibrinogen showed a significant association with reduced eGFRcystC only after adjusting for confounders (p = 0.048). Among PLWH on ART, D-dimer remained independently associated with reduced eGFRcystC, while fibrinogen showed an independent association after adjustment (β = -1.54, p = 0.031). Elevated fibrinogen levels were associated with an increased odds of CKD in the overall PLWH group (AOR = 1.12, 95% CI 1.00-1.23, p = 0.0 41), and elevated D-dimer levels were associated with increased odds of CKD among those on ART (AOR = 1.01, 95% CI 1.00-1.03, p = 0.045).

Conclusion: The study reveals that both D-dimer and fibrinogen, key markers of coagulation are independently associated with renal function decline and risk of CKD in PLWH, particularly those on ART. These findings suggest that coagulation activation may be an early indicator of declining kidney function and increased risk of CKD in PLWH, potentially preceding overt systemic inflammation.

南非艾滋病毒感染者凝血与肾功能下降和慢性肾病有关。
背景:慢性炎症是人类免疫缺陷病毒(HIV)感染的一个充分证明的特征,并与包括慢性肾脏疾病(CKD)在内的几种合并症的进展有关。值得注意的是,慢性凝血激活是HIV感染者(PLWH)慢性炎症介导的另一种常见现象,也与CKD进展有关。然而,在非洲HIV高流行人群中,炎症、凝血和肾功能障碍之间的关系仍未得到充分探讨。本研究调查了PLWH,特别是接受抗逆转录病毒治疗(ART)的患者的全身性炎症、凝血激活和肾功能之间的关系。方法:在这项横断面研究中,纳入了151名成年人,其中包括80名接受抗逆转录病毒治疗的艾滋病毒感染者,27名未接受抗逆转录病毒治疗的艾滋病毒感染者和44名非艾滋病毒感染者(PNLWH)。测量炎症标志物,C反应蛋白(CRP)和凝血标志物,包括纤维蛋白原和d -二聚体,并使用估计的肾小球滤过率(eGFR)来确定CKD分期,eGFR是根据胱抑素C (cystC)水平(eGFRcystC)计算的。结果:在整个PLWH队列中,d -二聚体在粗分析(p = 0.004)和校正分析(p = 0.014)中均与eGFRcystC降低显著相关,表明肾功能较差。仅在调整混杂因素后,纤维蛋白原显示与eGFRcystC降低有显著关联(p = 0.048)。在接受ART治疗的PLWH中,d -二聚体与eGFRcystC的降低仍然独立相关,而调整后纤维蛋白原与eGFRcystC的降低独立相关(β = -1.54, p = 0.031)。在整个PLWH组中,纤维蛋白原水平升高与CKD的几率增加相关(AOR = 1.12, 95% CI 1.00-1.23, p = 0.0 41), d -二聚体水平升高与ART组中CKD的几率增加相关(AOR = 1.01, 95% CI 1.00-1.03, p = 0.045)。结论:本研究显示凝血关键标志物d -二聚体和纤维蛋白原均与PLWH患者肾功能下降和CKD风险独立相关,尤其是抗逆转录病毒治疗患者。这些发现表明凝血激活可能是PLWH患者肾功能下降和CKD风险增加的早期指标,可能先于明显的全身性炎症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书